🧪 UPDATED DAILY FROM CLINICALTRIALS.GOVSynced today

Find Clinical Trials for Your Rare Disease

10292+ recruiting trials across all rare diseases. Filter by phase, location, and condition.

Clinical trial records are synced from ClinicalTrials.gov.
Report missing data

Showing 20 of 10292 recruiting trials

NARecruitingNCT07292545

Video-Based Proprioceptive Exercise Program in ALS

🏥 Tarsus University📍 1 site📅 Started Jul 2025View details ↗
EARLY_Phase 1RecruitingNCT07072611

Clinical Trial to Evaluate Safety, Tolerability, and Pharmacokinetics of SOF-SKN in Healthy Participants

🏥 Noxopharm Limited📍 1 site📅 Started Jul 2025View details ↗
NARecruitingNCT06915324

Transcranial Direct Current Stimulation for Post Treatment Lyme Disease

👨‍⚕️ Brian A Fallon, MD, Columbia University📍 2 sites📅 Started Jul 2025View details ↗
RecruitingNCT07144332

This Study is to Estimate the Efficacy of Hemodialysis Alone for Uric Acid Clearance in Patients on Hemodialysis. In Order to Evaluate the Need of Adjuvant Uric Acid Lowering Therapy

🏥 Sohag University📍 1 site📅 Started Jul 2025View details ↗
NARecruitingNCT07117656

Project Vuselela Feasibility

🏥 Arizona State University📍 1 site📅 Started Jul 2025View details ↗
NARecruitingNCT07025954

Planned Delivery at 37 Versus 36 Weeks in Pregnancies With Placenta Previaand Accreta

👨‍⚕️ Zhijian Wang, MD, PhD, The Third Affiliated Hospital of Guangzhou Medical University📍 6 sites📅 Started Jul 2025View details ↗
NARecruitingNCT06954142

Restricted Versus Liberal Fluid Intake for Prevention of Bronchopulmonary Dysplasia

👨‍⚕️ Sven Schulzke, Prof.MD, University Children's Hospital Basel📍 9 sites📅 Started Jul 2025View details ↗
Phase 4RecruitingNCT07138144

Efficacy, Safety, and ToLerability of Switching to A Two-Drug Regimen With DTG/3TC Compared to Maintaining A Three-Drug REgimen With BIC/FTC/TAF or DTG/3TC/ABC in ViroLogically SupprEssed PeopLe Living With HIV After 24 and 48 Weeks of Follow-Up

🏥 José Antonio Mata Marín📍 1 site📅 Started Jul 2025View details ↗
NARecruitingNCT07146776

Treatment of Intrabony Defects With Injectable Platelet-Rich Fibrin and Xenogenic Grafts

🏥 Saglik Bilimleri Universitesi📍 1 site📅 Started Jul 2025View details ↗
Phase 1, PHASE2RecruitingNCT07070518

Study of GV20-0251 in Participants With Solid Tumor Malignancies

🏥 GV20 Therapeutics📍 3 sites📅 Started Jul 2025View details ↗
Phase 1RecruitingNCT07031713

Safety, Efficacy and Cellular Metabolic Dynamics of ct1192 in Patients With Moderate to Severe Refractory SLE

🏥 Union Hospital, Tongji Medical College, Huazhong University of Science and Technology📍 1 site📅 Started Jul 2025View details ↗
RecruitingNCT07131774

Treatment Monitoring for NTM Infections With a Symptom Diary

👨‍⚕️ Christoph Lange, Prof. Dr. med. Dr. h.c., Clinical Infectious Diseases, Research Center Borstel, Leibniz Lung Center📍 3 sites📅 Started Jul 2025View details ↗
Phase 1RecruitingNCT07044271

A Study of Multiple Olomorasib (LY3537982) Capsules in Healthy Participants

👨‍⚕️ Call 1-877-CTLILLY (1-877-285-4559) or 1-317-615-4559 Mon - Fri 8 AM - 8 PM Eastern time (UTC/GMT - 5 hours, EST), Eli Lilly and Company📍 2 sites📅 Started Jul 2025View details ↗
Phase 3RecruitingNCT07047456

Effect of Stem Cell Infusion Time on aGVHD in Patients With Hematological Malignancies Post UCBT

👨‍⚕️ Xiaoyu Zhu, Ph.D, The First Affiliated Hospital of USTC📍 1 site📅 Started Jul 2025View details ↗
RecruitingNCT07343271

Dual-energy CT vs. MRI in the Evaluation of Squamous Cell Carcinomas of the Oral Cavity and Oropharynx

🏥 University Hospital, Strasbourg, France📍 1 site📅 Started Jul 2025View details ↗
Phase 3RecruitingNCT07100990

Treatment of Inflammatory Myelitis and Optic Neuritis With Early vs Rescue Plasma Exchange (TIMELY-PLEX)

👨‍⚕️ John Chen, Mayo Clinic📍 24 sites📅 Started Jul 2025View details ↗
NARecruitingNCT06895070

XVIVO Heart Box (XHB) With Supplemented XVIVO Heart Solution (SXHS) Continued Access Protocol (CAP)

👨‍⚕️ Sarah Lowe, XVIVO Perfusion📍 14 sites📅 Started Jul 2025View details ↗
RecruitingNCT06793709

A Post-marketing Observational Study of Tasfygo in Participants With Unresectable Biliary Tract Cancer With Fibroblast Growth Factor Receptor 2 (FGFR2) Fusion Gene Positivity Who Progressed After Chemotherapy

🏥 Eisai Co., Ltd.📍 1 site📅 Started Jul 2025View details ↗
RecruitingNCT06964685

Assessment of Support With Impella® Best Practices in Acute Myocardial Infarction Complicated by Cardiogenic Shock

🏥 Abiomed Inc.📍 10 sites📅 Started Jul 2025View details ↗
Phase 1RecruitingNCT06649227

Study Investigating the Safety of CD19 CAR-T Cells in Relapsed/Refractory AML Expressing CD19

👨‍⚕️ Ibrahim Yakoub-Agha, MD,PhD, University Hospital, Lille📍 1 site📅 Started Jul 2025View details ↗
← PreviousPage 88 of 515Next →

Get alerts when new trials open

Create a free account to follow conditions and receive trial notifications.

Create free account →